Another retrospective study showed that increased levels of eosinophils, serum IL-6, IL-10, and immunoglobulin E in peripheral blood were closely associated with the exacerbation of skin toxicity (Phillips et al., 2019), suggesting that these cytokines may be potential therapeutic targets for skin-related adverse reactions. The gene discussed is IL6; the disease is dermatological toxicity.